Wessel Terpstra

Sylics

Sylics offers innovative research solutions for preclinical neuroscience. We specialize in developing and employing mouse models and behavioural tests to evaluate compound effects on, and disease mechanisms of, neurological and psychiatric diseases, with a strong focus on Alzheimer's disease, Parkinson's disease and Schizophrenia. Sylics is a research intensive company that develops research solutions in preclinical neuroscience. Sylics CRO runs preclinical neuroscience studies for national and international biotech, food & pharma partners in a facility in Amsterdam. These studies focus on assessing the effect of novel therapeutic strategies to treat brain diseases such as Alzheimer's disease and Schizophrenia. Sylics Bioinformatics provides data analyses services to customers worldwide, using its proprietary cloud-based data analysis platform AHCODA™. This automated screening platform increases efficiency and sensitivity to detect behavioural deficits in mouse models. Over the last 10 years, we successfully characterized dozens of novel mouse models, and determined compound efficacy and side-effects in numerous projects for academia, biotech, and food industry clients.